The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase IB study of CX-4945 in combination with gemcitabine plus cisplatin in the frontline systemic treatment of patients with advanced cholangiocarcinoma.
 
Mitesh J. Borad
No Relationships to Disclose
 
Joleen Marie Hubbard
Consulting or Advisory Role - Bayer (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Genentech (Inst); PRISM Pharma (Inst); Senhwa Biosciences (Inst)
 
Do-Youn Oh
No Relationships to Disclose
 
Sun Young Rha
No Relationships to Disclose
 
Kabir Mody
No Relationships to Disclose
 
John K.C. Lim
Employment - Senhwa Biosciences
Stock and Other Ownership Interests - Senhwa Biosciences
 
Donald A. Richards
Consulting or Advisory Role - Boehringer Ingelheim; Insys Therapeutics; IntegraGen; Lilly; Pharmacyclics
Speakers' Bureau - Celgene